Voluntis And AstraZeneca To Test Companion Mobile App In Ovarian Cancer Studies With The US National Cancer Institute

Corporate Breaking News

Home : Voluntis And AstraZeneca To Test Companion Mobile App In Ovarian Cancer Studies With The US National Cancer Institute

Dec 07 2015	Voluntis And AstraZeneca To Test Companion Mobile App In Ovarian Cancer Studies With The US National Cancer Institute
PARIS, Dec. 7, 2015 /PRNewswire/ -- Voluntis and AstraZeneca today announced plans to test a digital support service for women undergoing treatment for recurrent platinum-sensitive high-grade ovarian cancer in clinical trials of cediranib plus olaparib. The service has been developed...


Source:http://www.prnewswire.com/news-releases/voluntis-and-astrazeneca-to-test-companion-mobile-app-in-ovarian-cancer-studies-with-the-us-national-cancer-institute-300188284.html

Related News
» Mobile Games and Social e-commerce in China Continue to Power MNC MEDIA's Revenue Growth » La solution eFront Investor Cloud pour les Limited Partners consolide sa position de leader